Aortobifemoral Bypass for Peripheral Arterial Disease
Aortobifemoral Bypass for Peripheral Arterial DiseaseSkip to the navigationSurgery OverviewAortobifemoral bypass surgery is used to bypass diseased large
blood vessels in the abdomen and groin. To bypass a narrowed or blocked blood vessel, blood is redirected through a
graft made of synthetic material (such as polytetrafluoroethylene [PTFE] or
Dacron). This graft is sewn above and below the diseased artery so that blood
flows through the graft. These man-made grafts are more likely to be used than
transplanted natural grafts for aortobifemoral surgery, because the blood
vessels involved are large. The artificial blood vessel is formed into a Y shape. The single
end of the Y is sewn on the aorta. The two split ends of the Y are sewn below
the blocked or narrowed areas of the femoral arteries. This allows the blood to
travel around (bypass) the diseased areas. General anesthesia is used and will cause you to sleep through the
procedure. What To Expect After SurgeryYou may stay in the hospital 4 to 7 days. And you can expect your belly and groin to be sore for several weeks. You will probably feel more tired than usual for several weeks.
You may be able to do many of your usual activities after 4 to 6 weeks. But you will likely need 2 to 3 months to fully recover, especially if you typically do a lot of physical activities. You will probably need to take at least 4 to 6 weeks off from work. It depends on the type of work you do and how you feel. Why It Is DoneAortobifemoral bypass surgery is for people who have narrowed or blocked blood
vessels (aorta or iliac arteries) in the abdomen and pelvis. Usually the
disease must be causing significant symptoms or be limb-threatening before
bypass surgery is considered.footnote 1, footnote 2 RisksAll surgeries carry a certain amount of risk. These risks include: - Infection from the
incision.
- Bleeding.
- Heart attack or stroke.
Specific risks for aortobifemoral bypass surgery include: - Leg swelling.
- Failed or blocked
grafts.
- Sexual dysfunction caused by nerve
damage in the pelvis.
ReferencesCitations- Gerhard-Herman MD, et al. (2016). 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. Circulation, published online November 13, 2016. DOI: 10.1161/CIR.0000000000000471. Accessed November 25, 2016.
- Conte MS, et al. (2015). Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. Journal of Vascular Surgery, 61(3S): 2S-41S. DOI: 10.1016/j.jvs.2014.12.009. Accessed November 25, 2016.
Other Works Consulted- Conte MS, et al. (2015). Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. Journal of Vascular Surgery, 61(3S): 2S-41S. DOI: 10.1016/j.jvs.2014.12.009. Accessed November 25, 2016.
- Gerhard-Herman MD, et al. (2016). 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. Circulation, published online November 13, 2016. DOI: 10.1161/CIR.0000000000000471. Accessed November 25, 2016.
CreditsByHealthwise Staff
Primary Medical ReviewerRakesh K. Pai, MD, FACC - Cardiology, Electrophysiology
Martin J. Gabica, MD - Family Medicine
Adam Husney, MD - Family Medicine
E. Gregory Thompson, MD - Internal Medicine
Specialist Medical ReviewerDavid A. Szalay, MD - Vascular Surgery Current as ofApril 24, 2017 Current as of:
April 24, 2017 Gerhard-Herman MD, et al. (2016). 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. Circulation, published online November 13, 2016. DOI: 10.1161/CIR.0000000000000471. Accessed November 25, 2016. Conte MS, et al. (2015). Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. Journal of Vascular Surgery, 61(3S): 2S-41S. DOI: 10.1016/j.jvs.2014.12.009. Accessed November 25, 2016. Last modified on: 8 September 2017
|
|
|
|
|
|